Section Arrow
IBIO.NASDAQ
- iBio
Quotes are at least 15-min delayed:2025/07/25 15:51 EDT
After Hours
Last
 --
-- (--)
Bid
--
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 0.7254
-0.0142 (-1.92%)
Day High 
0.743 
Prev. Close
0.7396 
1-M High
0.8668 
Volume 
253.27K 
Bid
0.7252
Ask
0.738
Day Low
0.725 
Open
0.74 
1-M Low
0.68 
Market Cap 
12.00M 
Currency USD 
P/E 0.65 
%Yield -- 
10-SMA 0.75 
20-SMA 0.76 
50-SMA 0.81 
52-W High 6.890841 
52-W Low 0.6358 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.32/-2.05
Enterprise Value
15.50M
Balance Sheet
Book Value Per Share
0.70
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
225.00K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NCNANuCana plc0.0591+0.0051+9.44%-- 
After Hours -- -- --
TNFATNF Pharmaceuticals Inc.0.1173-0.0147-11.14%-- 
After Hours -- -- --
ABPAbpro Holdings Inc0.3089+0.0428+16.08%-- 
After Hours -- -- --
PHIOPhio Pharmaceuticals Corp2.67+0.16+6.37%0.01PE
After Hours -- -- --
IOVAIovance Biotherapeutics3.13-0.16-4.86%-- 
After Hours -- -- --
Quotes are at least 15-min delayed:2025/07/25 15:51 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.